BCL2 and B-cell chronic lymphocytic leukemia: Previous studies have demonstrated that GSK-3 inhibition in CLL cells results in a reduction in BCL2 mRNA expression through an epigenetic mechanism, potentially mediating its induction of apoptosis [7].